Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reetu Mukherji

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Abdominal Radiology (New York)|May 28, 2026
Review of systemic therapy in HCC with an approach to response assessment in clinical practiceKevin A Zand, Tae-Hyung Kim, Reetu Mukherji, et al.
NPJ Precision Oncology|July 8, 2025
A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancerNarayanan Sadagopan, Hongkun Wang, Chao Yin, et al.
Biology Direct|June 6, 2022
The current state of molecular profiling in gastrointestinal malignanciesReetu Mukherji, Chao Yin, Rumaisa Hameed, et al.
Cancers|March 29, 2023
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and <i>COP1</i> in MetastasisJerry Xiao, Utsav Sharma, Abolfazl Arab, et al.
JNCI Cancer Spectrum|January 15, 2025
Rethinking the rise of early-onset gastrointestinal cancers: a call to actionBenjamin A Weinberg, Caitlin C Murphy, David R Freyer, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Abdominal Radiology (New York)|May 28, 2026
Review of systemic therapy in HCC with an approach to response assessment in clinical practiceKevin A Zand, Tae-Hyung Kim, Reetu Mukherji, et al.
NPJ Precision Oncology|July 8, 2025
A phase II single-arm study of combination pembrolizumab and olaparib in the treatment of patients with advanced biliary tract cancerNarayanan Sadagopan, Hongkun Wang, Chao Yin, et al.
Biology Direct|June 6, 2022
The current state of molecular profiling in gastrointestinal malignanciesReetu Mukherji, Chao Yin, Rumaisa Hameed, et al.
Cancers|March 29, 2023
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and <i>COP1</i> in MetastasisJerry Xiao, Utsav Sharma, Abolfazl Arab, et al.
JNCI Cancer Spectrum|January 15, 2025
Rethinking the rise of early-onset gastrointestinal cancers: a call to actionBenjamin A Weinberg, Caitlin C Murphy, David R Freyer, et al.
Pageof 2